Description
Rabbit Polyclonal CXCR4 (N-Terminus) Antibody (Human, Mouse, Rat)
| Catalog number: | B2022680 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | 39.746 kDa |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Rabbit Anti-CXCR4 Antibody, Rabbit Polyclonal Anti-CXCR4 Antibody, CXCR4 Rabbit Antibody, CXCR4 Polyclonal Antibody, Anti-CXCR4 Antibody (Rabbit), Rabbit CXCR4 Antibody, CXCR4 N-Terminus Antibody, CXCR4 Antibody (Rabbit, Human, Mouse, Rat), Rabbit CXCR4 N-Terminus Antibody, Polyclonal Rabbit CXCR4 Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Zlotnik, A., & Yoshie, O. (2000). Chemokines: A new classification system and their role in immunity. *Immunity*, 12(2), 121-127.
- Balkwill, F. (2004). Cancer and the chemokine network. *Nature Reviews Cancer*, 4(7), 540-550.
- Mller, A., Homey, B., Soto, H., et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. *Nature*, 410(6824), 50-56.
- Hwang, S. Y., & Kim, H. J. (2010). CXCR4 and its role in cancer metastasis. *Journal of Cancer Research and Clinical Oncology*, 136(12), 1791-1800.
- Sun, Y., & Zhang, Y. (2013). The role of CXCR4 in cancer metastasis. *Cancer Letters*, 328(2), 141-147.
- Kucia, M., et al. (2005). The role of the chemokine receptor CXCR4 in cancer metastasis. *Clinical Cancer Research*, 11(24), 8685-8692.
- Ratajczak, M. Z., et al. (2006). The role of the CXCR4/SDF-1 axis in cancer metastasis. *Cancer Letters*, 238(1), 1-10.
- Orimo, A., et al. (2005). Stromal fibroblasts in cancer: A new target for therapy. *Nature Reviews Cancer*, 5(1), 29-40.
- Salcedo, R., et al. (2000). The chemokine SDF-1/CXCL12 is a potent angiogenic factor. *The Journal of Experimental Medicine*, 192(5), 659-670.
- Duda, D. G., et al. (2010). CXCR4 inhibition in cancer: A new therapeutic target. *Clinical Cancer Research*, 16(24), 6100-6108.
